From the coal face: the Victorian experience - Dr Keri Alexander - DrugInfo   seminar - New and emerging drugs
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share

From the coal face: the Victorian experience - Dr Keri Alexander - DrugInfo seminar - New and emerging drugs

  • 607 views
Uploaded on

Patients presenting with complications from new and emerging drugs are appearing in the hospital system. Currently, there is little known about how best to treat them. Presentations include......

Patients presenting with complications from new and emerging drugs are appearing in the hospital system. Currently, there is little known about how best to treat them. Presentations include requests for detoxification, as well as crisis, e.g. acute psychiatric complications. No practical screening system is in place, so this is an example of how we have to adapt to the circumstances. Dr Alexander presents a case study.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
607
On Slideshare
452
From Embeds
155
Number of Embeds
4

Actions

Shares
Downloads
2
Comments
0
Likes
0

Embeds 155

http://www.druginfo.adf.org.au 149
http://druginfo.salsadigitalhosting.com.au 3
http://druginfo.aws1.salsadigitalhosting.com.au 2
http://druginfo.adf.org.au 1

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. New & Emerging Drugs At the Coal Face: The Victorian Experience Dr Keri Alexander Addiction Medicine Specialist Turning Point Eastern Health YSAS
  • 2. The Big Unknown • • • • Patients aren’t screened Patients / carers aren’t divulging No monitoring from the hospitals Anecdotal from professional networks eg VAILA (hospital D&A nurses and specialists) • Unknown drug content
  • 3. What about monitoring from DACAS? • Inherently biased/ opportunistic calls • Ad hoc reporting • Nil strategic research data collection and analysis
  • 4. How to treat ???
  • 5. Case of SW • • • • 22yr old man 6 year history of cannabis use First two years were marijuana Past 4 years were synthetic cannabis
  • 6. Case SW cont • Reported escalating tolerance to each brand/ product over time, relieved by switching brands • History of withdrawal symptoms, which varied between brands (possibly co-incidental) • Costs $400 per week ie $20,000 per year